USA Financial Formulas’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.16K Sell
26
-431
-94% -$52.6K ﹤0.01% 346
2026
Q2
$51.8K Sell
457
-4,747
-91% -$471K 0.01% 274
2026
Q1
$490K Buy
5,204
+3
+0.1% +$299 0.09% 79
2025
Q4
$514K Buy
+5,201
New +$503K 0.09% 81
2025
Q2
– Sell
-11,937
Closed -$723K – 303
2025
Q1
$723K Buy
+11,937
New +$832K 0.12% 72
2023
Q4
– Sell
-9,945
Closed -$575K – 440
2023
Q3
$575K Hold
9,945
– – 0.86% 33
2023
Q2
$619K Sell
9,945
-2,062
-17% -$138K 0.95% 40
2023
Q1
$868K Buy
+12,007
New +$939K 1.41% 28
2022
Q3
$1.24M Buy
+18,571
New +$1.37M 1.95% 14

Other funds holding INCY

USA Financial Formulas's INCY Position: Q3 2026 in Review

USA Financial Formulas reduced its Incyte (INCY) stake by 94% in Q3 2026, selling an estimated $52.6K and leaving 26 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

USA Financial Formulas first reported a position in INCY in Q3 2022 and has held it in 9 quarters since. The position peaked at $1.24M in Q3 2022. 899 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • USA Financial Formulas held 26 shares of Incyte worth $3.16K as of Q3 2026.
  • USA Financial Formulas sold 431 Incyte shares in Q3 2026, an estimated $52.6K.
  • Incyte made up ﹤0.01% of USA Financial Formulas's portfolio in Q3 2026, its #346 holding.
  • USA Financial Formulas first reported a position in Incyte in Q3 2022 and has held it in 9 quarters since.
  • USA Financial Formulas's Incyte position peaked at $1.24M in Q3 2022.
  • 899 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.